Literature DB >> 29110280

Body weight and mortality in COPD: focus on the obesity paradox.

Francesco Spelta1, A M Fratta Pasini2, L Cazzoletti3, M Ferrari4.   

Abstract

The positive association between overweight, obesity, and cardiovascular and all-cause mortality is well established, even though this relation is typically U shaped with an increased risk also in low-weight subjects. However, being overweight or obese has been associated with a better prognosis in subjects suffering from chronic diseases, id est the "obesity paradox". In both community-dwelling and hospitalized patients with COPD, several studies have reported a significant protective effect of obesity on all-cause mortality, indicating that also in obstructive pulmonary diseases, an obesity paradox may be present. Interestingly, the "paradox" is more evident for subjects with severe bronchial obstruction (i.e., a lower FEV1), while in mild-moderate conditions, the weight-related mortality shows a behavior similar to that observed in the general population. Several factors may confound the relation between COPD, obesity and mortality. The lower FEV1 found in obese people may be linked to a restrictive defect rather than to an obstructive one. Due to the modified chest wall mechanical properties-related to increased fat mass-obese COPD patients may present, respect to their lean counterpart, a lower lung hyperinflation which is associated with higher mortality. The traditional classification of COPD attributes to obese "blue bloaters" a low-grade emphysema in opposition to lean "pink puffers"; the fact that emphysema extent is related to mortality may bias the relationship between weight and survival. It is also to underline that the majority of the studies, consider BMI rather than body composition (a better predictor of mortality) when studying the intriguing relation between weight, COPD, and mortality. Reverse bias has also to be taken into account, hypothesizing that an unintentional weight loss may be the deleterious factor related to mortality, rather than considering obesity a protective one. Further prospective studies are needed to shed light on the complexity of this emerging issue. LEVEL OF EVIDENCE: Level V: Narrative Review.

Entities:  

Keywords:  COPD; Obesity; Obesity paradox; Overweight; Pulmonary function; Visceral obesity

Mesh:

Year:  2017        PMID: 29110280     DOI: 10.1007/s40519-017-0456-z

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  66 in total

Review 1.  Respiratory function and the obesity paradox.

Authors:  Jordan A Guenette; Dennis Jensen; Denis E O'Donnell
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-11       Impact factor: 4.294

2.  Body composition and mortality in chronic obstructive pulmonary disease.

Authors:  Annemie M W J Schols; Roelinka Broekhuizen; Clarie A Weling-Scheepers; Emiel F Wouters
Journal:  Am J Clin Nutr       Date:  2005-07       Impact factor: 7.045

3.  Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.

Authors:  Karine Marquis; Richard Debigaré; Yves Lacasse; Pierre LeBlanc; Jean Jobin; Guy Carrier; François Maltais
Journal:  Am J Respir Crit Care Med       Date:  2002-09-15       Impact factor: 21.405

4.  Effects of obesity on respiratory resistance.

Authors:  F Zerah; A Harf; L Perlemuter; H Lorino; A M Lorino; G Atlan
Journal:  Chest       Date:  1993-05       Impact factor: 9.410

5.  Obesity is a risk factor for dyspnea but not for airflow obstruction.

Authors:  Don D Sin; Richard L Jones; S F Paul Man
Journal:  Arch Intern Med       Date:  2002-07-08

6.  Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study.

Authors:  E Prescott; T Almdal; K L Mikkelsen; C L Tofteng; J Vestbo; P Lange
Journal:  Eur Respir J       Date:  2002-09       Impact factor: 16.671

7.  Per cent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort study.

Authors:  Elizabeth C Oelsner; J Jeffrey Carr; Paul L Enright; Eric A Hoffman; Aaron R Folsom; Steven M Kawut; Richard A Kronmal; David J Lederer; Joao A C Lima; Gina S Lovasi; Benjamin M Smith; Steven J Shea; R Graham Barr
Journal:  Thorax       Date:  2016-04-05       Impact factor: 9.139

Review 8.  Obesity and Prevalence of Cardiovascular Diseases and Prognosis-The Obesity Paradox Updated.

Authors:  Carl J Lavie; Alban De Schutter; Parham Parto; Eiman Jahangir; Peter Kokkinos; Francisco B Ortega; Ross Arena; Richard V Milani
Journal:  Prog Cardiovasc Dis       Date:  2016-01-28       Impact factor: 8.194

9.  Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Mitja Lainscak; Stephan von Haehling; Wolfram Doehner; Irena Sarc; Tina Jeric; Kristina Ziherl; Mitja Kosnik; Stefan D Anker; Stanislav Suskovic
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-03-01       Impact factor: 12.910

10.  Body mass index and mortality in chronic obstructive pulmonary disease: A dose-response meta-analysis.

Authors:  Yibin Guo; Tianyi Zhang; Zhiyong Wang; Feifei Yu; Qin Xu; Wei Guo; Cheng Wu; Jia He
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more
  25 in total

1.  Effects of Obstructive Sleep Apnea and Obesity on 30-Day Readmissions in Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Mediation Analysis.

Authors:  Jessica E Channick; Nicholas J Jackson; Michelle R Zeidler; Russell G Buhr
Journal:  Ann Am Thorac Soc       Date:  2022-03

2.  Investigation of the Obesity Paradox in Chronic Obstructive Pulmonary Disease, According to Smoking Status, in the United States.

Authors:  Tianshi David Wu; Chinedu O Ejike; Robert A Wise; Meredith C McCormack; Emily P Brigham
Journal:  Am J Epidemiol       Date:  2019-11-01       Impact factor: 4.897

Review 3.  Obesity paradox and aging.

Authors:  Ottavio Bosello; Angiola Vanzo
Journal:  Eat Weight Disord       Date:  2019-12-21       Impact factor: 4.652

Review 4.  Food Pyramid for Subjects with Chronic Obstructive Pulmonary Diseases.

Authors:  Mariangela Rondanelli; Milena Anna Faliva; Gabriella Peroni; Vittoria Infantino; Clara Gasparri; Giancarlo Iannello; Simone Perna; Tariq AbdulKarim Alalwan; Salwa Al-Thawadi; Angelo Guido Corsico
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-06-19

Review 5.  Obesity or BMI Paradox? Beneath the Tip of the Iceberg.

Authors:  Lorenzo Maria Donini; Alessandro Pinto; Anna Maria Giusti; Andrea Lenzi; Eleonora Poggiogalle
Journal:  Front Nutr       Date:  2020-05-07

Review 6.  Obesity paradox and heart failure.

Authors:  Maria Pia Donataccio; Angiola Vanzo; Ottavio Bosello
Journal:  Eat Weight Disord       Date:  2020-08-26       Impact factor: 4.652

7.  Outcomes of Idiopathic Pulmonary Fibrosis Improve with Obesity: A Rural Appalachian Experience.

Authors:  Rahul G Sangani; Andrew J Ghio; Hasan Mujahid; Zalak Patel; Kristen Catherman; Sijin Wen; John E Parker
Journal:  South Med J       Date:  2021-07       Impact factor: 0.810

Review 8.  Should patients with obesity be more afraid of COVID-19?

Authors:  Anna Maria Rychter; Agnieszka Zawada; Alicja Ewa Ratajczak; Agnieszka Dobrowolska; Iwona Krela-Kaźmierczak
Journal:  Obes Rev       Date:  2020-06-24       Impact factor: 10.867

9.  Determinants of impaired lung function and lung cancer prediction among never-smokers in the UK Biobank cohort.

Authors:  Matthew T Warkentin; Stephen Lam; Rayjean J Hung
Journal:  EBioMedicine       Date:  2019-09-05       Impact factor: 8.143

10.  Differences in the Outcome of Patients with COPD according to Body Mass Index.

Authors:  Zichen Ji; Javier de Miguel-Díez; Christian Reynaldo Castro-Riera; José María Bellón-Cano; Virginia Gallo-González; Walther Iván Girón-Matute; Rodrigo Jiménez-García; Ana López-de Andrés; Virginia Moya-Álvarez; Luis Puente-Maestu; Julio Hernández-Vázquez
Journal:  J Clin Med       Date:  2020-03-05       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.